30mg
Lyophilized Vial
For Research Purposes Only
Trizepatide
30mg
Higher-dose dual GIP/GLP-1 receptor agonist
Back in Stock Soon
$95.00AUD / single
Buy 3 — Save 10%$85.50 each3 for $256.50 — save $28.50
Gallery
Product Images
Description
About Trizepatide
A higher-concentration dual GIP/GLP-1 receptor agonist for preclinical metabolic research, studied for effects on weight regulation, glycemic control, and appetite signaling.
Composition
Ingredients
- ◆Trizepatide (30mg lyophilized)
- ◆Mannitol carrier
Research Applications
Studied Benefits
01
Studied for dual incretin receptor agonism at extended dosing ranges
02
Investigated in weight and adiposity research models
03
Explored for glucose homeostasis and satiety pathways
Important
Not for human consumption. Sold strictly for in-vitro research and laboratory use. Buyer assumes all responsibility for use.